Fluoxetine 병용 투여 후 만성 정신분열증 환자에서 혈장 5-Hydroxyindoleacetic Acid 농도에 따른 Hamilton Rating Scale for Depression의 변화
- Alternative Title
- Changes of Hamilton Rating Scale for Depression According to Plasma 5-Hydroxyindoleacetic Acid Level after Adjuntive Fluoxetine Trial in Schizophrenic Patients
- Abstract
- Object : The aim of this study was to examine an association between plasma 5-Hydroxyindoleacetic Acid(HIAA) level and the change of depressive symptom after fluoxetine trial in haloperidol-stabilized schizoprenic in-patients. Method : According to plasma 5-HIM level, 32 patients were classified to either group with high 5-HIAA level(N=11) or that with low 5-HIM(N=11). For each patient, fluoxetine(20mg/day) added to stable haloperidol dose for 6 weeks. The authors measured Hamilton Rating Scale for Depression (HRSD) at baseline, the 2nd week, the 4th week, the 6th week of treatment. Result : 1) Age, duration of illness, number of admission, duration of present admission, dosage of haloperidol between high 5-HIAA group and low 5-HIM group were significantly different. 2) As time went on, the association between the change of depressive symptom and plasma 5-HIAA concentration was not significant. 3) Of depressed group, as lime went an, depressive symptoms were improved significantly in high 5-HIAA group, but not in law 5-HIM group. Conclusion : We suggest that the association between plasma 5-HIAA level and the change of depressive symptoms after fluoxetine trial in haloperidol stabilized schizophrenic in-patients was not significant.
- All Author(s)
- 심세훈
; 정한용
; 한선호
- Issued Date
- 1996
- Type
- Article
- Keyword
- schizophrenia; 5-HIAA; fluoxetine; HRSD
- Publisher
- 대한생물정신의학회
- ISSN
- 1225-8709
; 2005-7571
- Citation Title
- 생물정신의학
Journal of Korean Society of Biological Psychiatry
- Citation Volume
- 3
- Citation Number
- 2
- Citation Start Page
- 269
- Citation End Page
- 276
- Language(ISO)
- eng
- URI
- http://schca-ir.schmc.ac.kr/handle/2022.oak/1748
- 공개 및 라이선스
-
- 파일 목록
-
Items in Repository are protected by copyright, with all rights reserved, unless otherwise indicated.